Jun 12, 2026 06:00AM
Jun 1, 2026 06:00AM
May 29, 2026 06:00AM
May 27, 2026 05:00PM
May 27, 2026 05:00PM
May 21, 2026 06:00AM
May 13, 2026 01:27PM BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
May 6, 2026 06:00AM
Apr 29, 2026 06:00AM
Apr 29, 2026 06:00AM
Feb 26, 2026 06:00AM
Jan 6, 2026 01:30PM
Dec 18, 2025 06:00AM
Dec 18, 2025 06:00AM BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
Dec 8, 2025 08:00AM
Dec 7, 2025 06:00PM
Nov 26, 2025 06:00AM
Nov 26, 2025 06:00AM
Nov 20, 2025 06:00AM
Nov 6, 2025 06:00AM
Oct 13, 2025 06:00AM BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
Aug 29, 2025 06:00AM
Aug 6, 2025 06:00AM
Jul 31, 2025 06:00AM
Jun 25, 2025 06:00AM
Jun 12, 2025 06:00AM
Jun 11, 2025 04:05PM
Jun 11, 2025 04:05PM U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications
May 31, 2025 08:00AM
May 14, 2025 04:05PM
May 7, 2025 06:00AM
Mar 4, 2025 06:00AM
Feb 27, 2025 06:00AM
Dec 27, 2024 06:01AM
Dec 27, 2024 06:00AM TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy
Dec 9, 2024 08:30PM
Nov 19, 2024 07:00AM
Nov 12, 2024 06:00AM
Oct 16, 2024 06:00AM
Sep 26, 2024 06:21PM
Aug 26, 2024 06:00AM
Aug 7, 2024 06:00AM BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
Jun 14, 2024 06:00AM
May 8, 2024 06:00AM
Apr 23, 2024 06:00AM
Mar 14, 2024 04:30PM
Mar 14, 2024 04:28PM
Mar 14, 2024 10:12AM
Mar 7, 2024 05:19PM BeiGene Announces FDA Accelerated Approval of BRUKINSA for the Treatment of Relapsed or Refractory Follicular Lymphoma
Feb 27, 2024 06:00AM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All